Literature DB >> 22426019

Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line.

Sihem Doggui1, Jasjeet Kaur Sahni, Madeleine Arseneault, Lé Dao, Charles Ramassamy.   

Abstract

Curcumin, a natural polyphenolic pigment present in the spice turmeric (Curcuma longa), is known to possess a pleiotropic activity such as antioxidant, anti-inflammatory, and anti-amyloid-β activities. However, these benefits of curcumin are limited by its poor aqueous solubility and oral bioavailability. In the present study, a polymer-based nanoparticle approach has been utilized to deliver drugs to neuronal cells. Curcumin was encapsulated in biodegradable poly (lactide-co-glycolide) (PLGA) based-nanoparticulate formulation (Nps-Cur). Dynamic laser light scattering and transmission electronic microscopy analysis indicated a particle diameter ranging from 80 to 120 nm. The entrapment efficiency was 31% with 15% drug-loading. In vitro release kinetics of curcumin from Nps-Cur revealed a biphasic pattern with an initial exponential phase followed by a slow release phase. Cellular internalization of Nps-Cur was confirmed by fluorescence and confocal microscopy with a wide distribution of the fluorescence in the cytoplasm and within the nucleus. The prepared nanoformulation was characterized for cellular toxicity and biological activity. Cytotoxicity assays showed that void PLGA-nanoparticles (Nps) and curcumin-loaded PLGA nanoparticles (Nps-Cur) were nontoxic to human neuroblastoma SK-N-SH cells. Moreover, Nps-Cur was able to protect SK-N-SH cells against H2O2 and prevent the elevation of reactive oxygen species and the consumption of glutathione induced by H2O2. Interestingly, Nps-Cur was also able to prevent the induction of the redox-sensitive transcription factor Nrf2 in the presence of H2O2. Taken together, these results suggest that Nps-Cur could be a promising drug delivery strategy to protect neurons against oxidative damage as observed in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426019     DOI: 10.3233/JAD-2012-112141

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  20 in total

Review 1.  Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.

Authors:  Shu Wang; Rui Su; Shufang Nie; Ming Sun; Jia Zhang; Dayong Wu; Naima Moustaid-Moussa
Journal:  J Nutr Biochem       Date:  2013-11-05       Impact factor: 6.048

Review 2.  Nanotechnology to improve the Alzheimer's disease therapy with natural compounds.

Authors:  Maria João Ramalho; Stephanie Andrade; Joana Angélica Loureiro; Maria do Carmo Pereira
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

Review 3.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

Review 4.  Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.

Authors:  Javed Ahmad; Sohail Akhter; Md Rizwanullah; Mohammad Ahmed Khan; Lucie Pigeon; Richard T Addo; Nigel H Greig; Patrick Midoux; Chantal Pichon; Mohammad Amjad Kamal
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

Review 5.  Therapeutic Applications of Curcumin Nanoformulations.

Authors:  Murali M Yallapu; Prashanth K Bhusetty Nagesh; Meena Jaggi; Subhash C Chauhan
Journal:  AAPS J       Date:  2015-09-03       Impact factor: 4.009

6.  Hydrogel Templates for Rapid Manufacturing of Bioactive Fibers and 3D Constructs.

Authors:  Ali Tamayol; Alireza Hassani Najafabadi; Bahar Aliakbarian; Elmira Arab-Tehrany; Mohsen Akbari; Nasim Annabi; David Juncker; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2015-08-25       Impact factor: 9.933

7.  Enhanced Therapeutic Potential of Nano-Curcumin Against Subarachnoid Hemorrhage-Induced Blood-Brain Barrier Disruption Through Inhibition of Inflammatory Response and Oxidative Stress.

Authors:  Zong-Yong Zhang; Ming Jiang; Jie Fang; Ming-Feng Yang; Shuai Zhang; Yan-Xin Yin; Da-Wei Li; Lei-Lei Mao; Xiao-Yan Fu; Ya-Jun Hou; Xiao-Ting Fu; Cun-Dong Fan; Bao-Liang Sun
Journal:  Mol Neurobiol       Date:  2015-12-26       Impact factor: 5.590

8.  Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect.

Authors:  Niloufar Ansari; Fariba Khodagholi
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

Review 9.  Flavonoid-Based Nanomedicines in Alzheimer's Disease Therapeutics: Promises Made, a Long Way To Go.

Authors:  Pragya Prasanna; Arun Upadhyay
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-27

Review 10.  Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease models.

Authors:  Palanivel Ganesan; Hyun-Myung Ko; In-Su Kim; Dong-Kug Choi
Journal:  Int J Nanomedicine       Date:  2015-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.